These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 229427)

  • 1. [Importance of HDL-cholesterol as a negative risk factor and the relationship between HDL and oral contraceptives].
    Arntzenius AC
    Ned Tijdschr Geneeskd; 1979 Nov; 123(44):1910-2. PubMed ID: 229427
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary atherosclerosis and plasma lipoproteins: epidemiology and pathophysiologic considerations.
    Miller NE
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S190-5. PubMed ID: 6177955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL-cholesterol as a negative risk factor.
    Rifkind BM
    Curr Concepts Nutr; 1981; 10():79-87. PubMed ID: 7249686
    [No Abstract]   [Full Text] [Related]  

  • 5. [The importance of HDL-cholesterol as a risk factor in coronary artery disease].
    Assmann G; Schriewer H; Schulte H; Oberwittler W
    Internist (Berl); 1980 Apr; 21(4):202-12. PubMed ID: 6998908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in serum lipoproteins in women treated with combined oral contraceptives].
    Bellod P; Serrano C; Díaz A; Tejero T; Nuño J; de Oya M
    Rev Clin Esp; 1983 Sep; 170(6):275-8. PubMed ID: 6658069
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of oral contraceptives on lipid metabolism.
    Krauss RM
    J Reprod Med; 1986 Jun; 31(6 Suppl):549-50. PubMed ID: 3723487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HDL cholesterol, a protective factor against coronary disease].
    Berchtold P; Berger M
    Dtsch Med Wochenschr; 1978 Oct; 103(40):1537-40. PubMed ID: 212261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Does HDL-cholesterol determination facilitate the assessment of risk in coronary patients?].
    Schmid B; Hartmann G
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1923-5. PubMed ID: 6665537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [VLDL catabolism: implication for negative-risk of HDL-cholesterol against ischemic heart disease (author's transl)].
    Nambu S; Tsushima M; Nishioeda Y; Murakami K; Ko H; Hayashi R; Nakao Y; Kajikawa T; Kushiro H
    Rinsho Byori; 1981 Nov; 29(11):1101-7. PubMed ID: 7334664
    [No Abstract]   [Full Text] [Related]  

  • 11. [HDL-cholesterol and coronary atherosclerosis].
    Forti N; Giannini SD; Diament J
    Arq Bras Cardiol; 1980 Jun; 34(6):485-91. PubMed ID: 7469810
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma high density lipoproteins and coronary artery disease.
    Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT
    Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen.
    Nash AL; Cornish EJ; Hain R
    Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemical basis for evaluating oral contraceptives.
    Briggs MH
    Aust Fam Physician; 1980 Feb; Suppl():25-9. PubMed ID: 7362529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-density lipoproteins in children with coronary diseases].
    Oberhänsli I; Pometta D; Micheli H; Raymond L
    Helv Paediatr Acta; 1981; 36(2):135-47. PubMed ID: 7251385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HDL cholesterol and coronary risk (author's transl)].
    de Backer G; Kornitzer M; Dramaix M; Sobolski J; Degré S; Pannier R; Denolin H
    Ann Cardiol Angeiol (Paris); 1980; 29(6):431-7. PubMed ID: 7458258
    [No Abstract]   [Full Text] [Related]  

  • 17. [LDL-cholesterol and HDL-cholesterol--risk factor and safety factor? Conclusions for therapy].
    Wolfram G; Schlierf G
    Internist (Berl); 1979 Dec; 20(12):613-8. PubMed ID: 232882
    [No Abstract]   [Full Text] [Related]  

  • 18. [HDL-cholesterol and family incidence of coronary disease in the Genevan population].
    Suenram A; Pometta D; von der Weid N
    Schweiz Med Wochenschr; 1983 Dec; 113(50):1926-8. PubMed ID: 6665538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HDL-cholesterol and the coronary risk profile of healthy men in our population].
    Hurych J; Kaucká J; Grafnetter D; Widimský J; Hejl Z; Rakická E
    Vnitr Lek; 1983 Oct; 29(10):937-44. PubMed ID: 6649450
    [No Abstract]   [Full Text] [Related]  

  • 20. Lowering of H.D.L. cholesterol by oral contraceptives.
    Roössner S
    Lancet; 1978 Jul; 2(8083):269. PubMed ID: 79069
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.